Parkinson's Disease Trial, By Invitation NCT04680130 Sponsor: Mayo Clinic Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, By Invitation

NCT04680130
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are over the age of 21.
  • People who have symptoms that suggest a neurodegenerative disease or a related condition.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have another illness that could fully explain all of their symptoms, such as a brain injury, brain inflammation (encephalitis), strokes, or developmental conditions.
  • Women who are currently pregnant, recently gave birth, or are breastfeeding.
  • People who have certain inherited genetic conditions that can raise the risk of cancer, including Cowden disease, Lynch syndrome, Hypogammaglobulinemia, Wiskott-Aldrich syndrome, or Down's syndrome.
  • People for whom an MRI scan would not be safe or suitable — for example, those with metal in the head, a heart pacemaker, severe fear of enclosed spaces, or certain brain abnormalities such as bleeding around the brain, a brain tumour, or large areas of brain damage from a prior stroke.
  • People who are medically unstable, or who are taking medications that could affect the brain's structure or activity, such as chemotherapy.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 24 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
1 November 2020
Est. completion
1 November 2050

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Imaging analysis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 24 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov